The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Prospective Study of Serologic Tests for Lyme Disease
Open accessAbstract
BACKGROUND: Tests to determine serum antibody levels-the 2-tier sonicate immunoglobulin M (IgM) and immunoglobulin G (IgG) enzyme-linked immunosorbent assay (ELISA) and Western blot method or the IgG of the variable major protein-like sequence-expressed (VlsE) sixth invariant region (C6) peptide ELISA method-are the major tests available for support of the diagnosis of Lyme disease. However, these tests have not been assessed prospectively. METHODS: We used these tests prospectively to determine serologic responses in 134 patients with various manifestations of Lyme disease, 89 patients with other illnesses (with or without a history of Lyme disease), and 136 healthy subjects from areas of endemicity and areas in which the infection was not endemic. RESULTS: With 2-tier tests and the C6 peptide ELISA, only approximately one-third of 76 patients with erythema migrans had results that were positive for IgM or IgG seroreactivity with Borrelia burgdorferi in acute-phase samples. During convalescence, 3-4 weeks later, almost two-thirds of patients had seroreactivity with the spirochete B. burgdorferi. The frequencies of seroreactivity were significantly greater among patients with spirochetal dissemination than they were among those who lacked evidence of disseminated disease. Of the 44 patients with Lyme disease who had neurologic, heart, or joint involvement, all had positive C6 peptide ELISA results, 42 had IgG responses with 2-tier tests, and 2 patients with facial palsy had only IgM responses. However, among the control groups, the IgG Western blot was slightly more specific than the C6 peptide ELISA. The differences between the 2 test systems (2-tier testing and C6 peptide ELISA) with respect to sensitivity and specificity were not statistically significant. CONCLUSIONS: Except in patients with erythema migrans, both test systems were sensitive for support of the diagnosis of Lyme disease. However, with current methods, 2-tier testing was associated with slightly better specificity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wormser, G. P., Dattwyler, R. J., Shapiro, E. D., Halperin, J. J., Steere, A. C., Klempner, M. S., Krause, P. J., Bakken, J. S., Strle, F., Stanek, G., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/508667 · Cited by 2,087
Self-citationSteere, A. C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107123450207 · Cited by 1,059
Self-citationDave, K. A., & White, S. W. (2002) · World Highways/Routes du Monde · Cited by 765
Klempner, M. S., Hu, L. T., Evans, J., Schmid, C. H., Johnson, G. M., Trevino, R. P., Norton, D., Levy, L., Wall, D., McCall, J., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107123450202 · Cited by 758
Western Blotting in the Serodiagnosis of Lyme Disease
Dressler, F., Whalen, J. A., Reinhardt, B. N., & Steere, A. C. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.2.392 · Cited by 694
Self-citationNocton, J. J., Dressler, F., Rutledge, B. J., Rys, P. N., Persing, D. H., & Steere, A. C. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300401 · Cited by 591
Self-citationA Critical Appraisal of “Chronic Lyme Disease”
Feder, H. M., Johnson, B. J. B., O'Connell, S., Shapiro, E. D., Steere, A. C., & Wormser, G. P. (2007) · New England Journal of Medicine · doi:10.1056/nejmra072023 · Cited by 578
Self-citationCase Definitions for Public Health Surveillance: (546082006-001)
Wharton, M., Chorba, T. L., Vogt, R. L., Morse, D. L., & Buehler, J. W. (1990) · PsycEXTRA Dataset · doi:10.1037/e546082006-001 · Cited by 454
Chronic Lyme borreliosis in the laboratory mouse.
Barthold, S. W., Souza, M. S., Janotka, J. L., Smith, A. L., & Persing, D. H. (1993) · PubMed · Cited by 329
Kalish, R. A., McHugh, G., Granquist, J., Shea, B., Ruthazer, R., & Steere, A. C. (2001) · Clinical Infectious Diseases · doi:10.1086/322669 · Cited by 322
Self-citation
Cited by
Stanek, G., Wormser, G. P., Gray, J., & Strle, F. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60103-7 · Cited by 1,237
Steere, A. C., Strle, F., Wormser, G. P., Hu, L. T., Branda, J. A., Hovius, J. W. R., Li, X., & Mead, P. S. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.90 · Cited by 845
Self-citationSudden Sensorineural Hearing Loss: A Review of Diagnosis, Treatment, and Prognosis
Kuhn, M., Heman-Ackah, S. E., Shaikh, J. A., & Roehm, P. C. (2011) · Trends in Amplification · doi:10.1177/1084713811408349 · Cited by 492
Human Granulocytic Anaplasmosis
Bakken, J. S., & Dumler, J. S. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.02.007 · Cited by 429
Lantos, P. M., Rumbaugh, J., Bockenstedt, L. K., Falck-Ytter, Y. T., Aguero-Rosenfeld, M. E., Auwaerter, P. G., Baldwin, K., Bannuru, R. R., Belani, K. K., Bowie, W. R., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1215 · Cited by 376
Self-citation
Metadata
- Authors
- Steere, A. C., McHugh, G., Damle, N., & Sikand, V. K.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-07-15
- Volume
- 47
- Issue
- 2
- Pages
- 188-195
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2171858853
- Cited by
- 279
- References
- 20
- FWCI
- 10.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prospective Study of Serologic Tests for Lyme Disease. https://app.cochat.ai/papers/10.1086/589242
- The paper
- Steere, A. C., McHugh, G., Damle, N., & Sikand, V. K. (2008). Prospective Study of Serologic Tests for Lyme Disease. Clinical Infectious Diseases. https://doi.org/10.1086/589242
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.